The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Oxovanadium IV     oxovanadium

Synonyms: CHEBI:30046, AC1L1QQX, VO(2+), [VO](2+), 20644-97-7, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of oxovanadium

 

Psychiatry related information on oxovanadium

  • Oxygen uptake (VO(2)) kinetics were defined as oxygen deficit (DeltaVO(2) x time [rest to steady state] - Sigma VO(2) [rest to steady state]) and mean response time (MRT = oxygen-deficit/DeltaVO(2)) [6].
  • There was no significant difference in breathing between groups during relaxed wakefulness (V, group A: 7.44 (SD 2.5) l.min(-1); group B: 6.02 (SD 1.3) l.min(-1); P(ET) CO(2), group A: 41.0 (SD 4.2) mm g; group B: 38.3 (SD2.0) mm Hg) or during exercise (V/VO(2): group A: 21 (SD 6. 0) l.min(-1)/l.min(-1); group B: 24 (SD 7.3) l.min(-1)/l.min(-1)) [7].
  • CONCLUSIONS: These results show that more participation in free-living physical activity is related to greater VO(2) max and less difficulty in being active [8].
  • The strength of the rationale for incorporating total body oxygen consumption (VO(2)) and delivery (DO(2)) into our decision making strategies contrasts with the absence of demonstrated benefits of bedside calculations in clinical practice [9].
 

High impact information on oxovanadium

  • The rate of O(2) consumption (VO(2)) remained constant until [O(2)] fell below 15 microM, whereas the onset of reduction of cytochromes aa(3), part of the terminal ETC enzyme cytochrome c oxidase, occurred at approximately 50 microM O(2) [10].
  • We propose a similar location compatible with all kinetic and spectroscopic results to account for the reactivity of VO(2+) and the VO(2+)-chelate in dUTP hydrolysis [11].
  • Catheterization-based invasive exercise testing revealed depressed changes in the exercise-induced cardiac index, systemic vascular resistance, stroke volume, and VO(2) in patients with Ile164 [12].
  • Maximum oxygen consumption (VO(2max)) and anaerobic threshold VO(2) were calculated with a SensorMedics Vmax29C analyzer (Sensor Medics, Yorba Linda, CA), and heart rate was measured by electrocardiogram [13].
  • The training group showed a significant improvement of aerobic capacity measured by anaerobic threshold VO(2) (14.67 +/- 3.03 versus 17.08 +/- 3.35 ml/kg/minute, P < 0.001) [13].
 

Chemical compound and disease context of oxovanadium

 

Biological context of oxovanadium

  • Measures of oxygen consumption (VO(2)) were recorded during the treadmill tests [18].
  • In the patients, the increase in cardiac output relative to VO(2) (mean DeltaQ/DeltaVO(2) = 15.0 +/- 13.6; range 3.3-73) and ventilation (mean peak VE/VO(2) = 65 +/- 24; range 21-104) were exaggerated compared with controls (mean DeltaQ/DeltaVO(2) = 5.1 +/- 0.7; VE/VO(2) = 41.2 +/- 7.4, P < 0.01) [19].
  • Minute ventilation (VE), oxygen uptake (VO(2)), ventilated carbon dioxide (VCO(2)) and heart rate were measured in patients achieving a respiratory quotient >1 (n = 30) [20].
  • In heart failure patients, peak VO(2) and forearm blood flow, but not left ventricular ejection fraction, increased after training [21].
  • Peak VO(2) (%predicted maximum) correlated best with the peak tidal volume attained (VT standardized as % of predicted vital capacity) (r = 0.68, p < 0.0005), which, in turn, correlated strongly with IC at peak exercise (r = 0.79, p < 0.0005) or at rest (r = 0.75, p < 0.0005) [22].
 

Anatomical context of oxovanadium

  • The effect of exercise intensity on skeletal muscle AMP-activated protein kinase (AMPK) signaling and substrate metabolism was examined in eight men cycling for 20 min at each of three sequential intensities: low (40 +/- 2% VO(2) peak), medium (59 +/- 1% VO(2) peak), and high (79 +/- 1% VO(2) peak) [23].
  • In a systematic effort to identify a potent anticancer agent, we synthesized 15 oxovanadium(IV) complexes and examined their cytotoxic activity against 14 different human cancer cell lines [24].
  • We evaluated lipid metabolism during 90 min of moderate-intensity (50% VO(2) peak) cycle ergometer exercise in five men and five women who were matched on adiposity (24 +/- 2 and 25 +/- 1% body fat, respectively) and aerobic fitness (VO(2) peak: 49 +/- 2 and 47 +/- 1 ml x kg fat-free mass(-1) x min(-1), respectively) [25].
  • 5. In conclusion, PPAHV produces vasoconstriction and a biphasic effect on VO(2) in the perfused rat hindlimb very similar to that induced by naturally occurring vanilloids [26].
  • This highly conserved relationship between alveolar architecture and VO(2) suggests the presence of similarly conserved mechanisms that control the onset, rate, and cessation of alveolus formation and alveolar size, which are also influenced by retinoids and thyroid and corticosteroid hormones [27].
 

Associations of oxovanadium with other chemical compounds

  • Results: Training increased oxygen consumption (VO(2)) peak [OW, 29 +/- 1 to 37 +/- 4 ml/kg fat-free mass (FFM).min; T2DM, 33 +/- 2 to 43 +/- 3 ml/kg FFM.min; P < 0.05] and improved insulin-stimulated glucose disposal (OW, 6.5 +/- 0.5 to 7.2 +/- 0.4 mg/kg FFM.min; T2DM, 3.8 +/- 0.3 to 4.2 +/- 0.3 mg/kg FFM.min; P < 0.05) in insulin resistance [28].
  • The effects of 11 divalent metal ions (Be(2+), Ca(2+), Cd(2+), Co(2+), Cu(2+), Hg(2+), Mn(2+), Ni(2+), Sr(2+), VO(2+), Zn(2+)) on ATPase activity were determined in the absence and presence of MgCl(2) [29].
  • We investigated the effects of increased O(2) tension at which Hb is 50% saturated (P(50)) on systemic O(2) uptake (VO(2) (SYS)), DO(2 CRIT), lactate production, and acid-base balance during isovolemic hemodilution in conscious rats [30].
  • 3. Capsazepine (10 microM) caused a parallel shift to the right of both VO(2) and PP concentration-response curves for PPAHV (pK(b)=5.00), indicative of competitive binding to vanilloid receptors [26].
  • We conclude that 1) the RTN is involved in the integration of VE, VO(2), T(re), and arousal and 2) TRH may establish the responsiveness of RTN neurons [31].
 

Gene context of oxovanadium

  • We found a threshold value of body mass index percentile (by age) of about 71, above which systematic changes in GHBP, IGFBP-1, and peak VO(2) per kilogram were noted, suggesting decreases in the following: 1) GH function, 2) insulin sensitivity, and 3) fitness [32].
  • Following a single bout of exercise at 40% and 75% of VO(2) max, an accumulation of myogenin in myonuclei and not in satellite cells was observed in biopsies from the exercised leg but not in biopsies before exercise and from the resting leg [33].
  • By intervention with exercise education, 30 overweight subjects showed reduction in BMI (29.0+/-2.2 to 28.0+/-2.0, P<0.001), V and S areas, increase in VO(2) and WR at VT, increase in bFGF (9.21+/-5.82-21.2+/-7.04 ng/ml, P<0.001), and no change in VEGF (1.45+/-0.72-1.88+/-0.52 ng/ml, P=0.016) [34].
  • We examined DH during exercise in 105 patients with COPD (FEV(1) = 37 +/- 13% predicted; mean +/- SD) and studied the relationships between resting lung volumes, DH during exercise, and peak oxygen consumption (VO(2)) [22].
  • Using a stepwise regression analysis, percentage predicted functional residual capacity (FRC), the activity of CS, oxygen desaturation during exercise, age, and inspiratory capacity (% pred) were found to be significant determinants of peak VO(2) [35].
 

Analytical, diagnostic and therapeutic context of oxovanadium

  • Comparison of the training group and control group after 12 weeks showed a significant difference relating to VO(2max) (24.31 +/- 4.61 versus 21.21 +/- 3.88 ml/kg/minute, P = 0.01) and anaerobic threshold VO(2) (17.08 +/- 3.35 versus 13.66 +/- 2.82 ml/kg/minute, P < 0.0001) [13].
  • BACKGROUND: Based on predicted survival, HF patients with peak VO(2) <14 ml/min/kg or medium- to high-risk HFSS are currently considered eligible for heart transplantation [36].
  • One-year event-free survival (without urgent transplantation or left ventricular assist device) was improved in the current era, regardless of initial peak VO(2): 64% vs. 48% for peak VO(2) <10 ml/min/kg (p = 0.09), 81% vs. 70% for 10 to 14 ml/min/kg (p = 0.05), and 93% vs. 82% for >14 ml/min/kg (p = 0.04) [36].
  • Of the patients with peak VO(2) of 10 to 14 ml/min/kg, 55% had low-risk HFSS and exhibited 88% one-year event-free survival [36].
  • Metabolic stress testing (VO(2)), pulmonary function tests and isokinetic strength testing were also performed [37].

References

  1. Beraprost therapy for pulmonary arterial hypertension. Barst, R.J., McGoon, M., McLaughlin, V., Tapson, V., Rich, S., Rubin, L., Wasserman, K., Oudiz, R., Shapiro, S., Robbins, I.M., Channick, R., Badesch, D., Rayburn, B.K., Flinchbaugh, R., Sigman, J., Arneson, C., Jeffs, R. J. Am. Coll. Cardiol. (2003) [Pubmed]
  2. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. de Groote, P., Dagorn, J., Soudan, B., Lamblin, N., McFadden, E., Bauters, C. J. Am. Coll. Cardiol. (2004) [Pubmed]
  3. Prognostic value of mechanical efficiency in ambulatory patients with idiopathic dilated cardiomyopathy in sinus rhythm. Kim, I.S., Izawa, H., Sobue, T., Ishihara, H., Somura, F., Nishizawa, T., Nagata, K., Iwase, M., Yokota, M. J. Am. Coll. Cardiol. (2002) [Pubmed]
  4. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. Linde, C., Leclercq, C., Rex, S., Garrigue, S., Lavergne, T., Cazeau, S., McKenna, W., Fitzgerald, M., Deharo, J.C., Alonso, C., Walker, S., Braunschweig, F., Bailleul, C., Daubert, J.C. J. Am. Coll. Cardiol. (2002) [Pubmed]
  5. Oxygen uptakes adjusted for body composition in normal-weight and obese adolescents. Ekelund, U., Franks, P.W., Wareham, N.J., Aman, J. Obes. Res. (2004) [Pubmed]
  6. Combining low-intensity and maximal exercise test results improves prognostic prediction in chronic heart failure. Rickli, H., Kiowski, W., Brehm, M., Weilenmann, D., Schalcher, C., Bernheim, A., Oechslin, E., Brunner-La Rocca, H.P. J. Am. Coll. Cardiol. (2003) [Pubmed]
  7. Unilateral focal lesions in the rostrolateral medulla influence chemosensitivity and breathing measured during wakefulness, sleep, and exercise. Morrell, M.J., Heywood, P., Moosavi, S.H., Guz, A., Stevens, J. J. Neurol. Neurosurg. Psychiatr. (1999) [Pubmed]
  8. Aerobic fitness, physiologic difficulty and physical activity in Black and White women. Hunter, G.R., Weinsier, R.L., Zuckerman, P.A., Darnell, B.E. Int. J. Obes. Relat. Metab. Disord. (2004) [Pubmed]
  9. Matching total body oxygen consumption and delivery: a crucial objective? Squara, P. Intensive care medicine. (2004) [Pubmed]
  10. Endogenous NO regulates superoxide production at low oxygen concentrations by modifying the redox state of cytochrome c oxidase. Palacios-Callender, M., Quintero, M., Hollis, V.S., Springett, R.J., Moncada, S. Proc. Natl. Acad. Sci. U.S.A. (2004) [Pubmed]
  11. Catalytic and structural role of the metal ion in dUTP pyrophosphatase. Mustafi, D., Bekesi, A., Vertessy, B.G., Makinen, M.W. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  12. Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure. Wagoner, L.E., Craft, L.L., Singh, B., Suresh, D.P., Zengel, P.W., McGuire, N., Abraham, W.T., Chenier, T.C., Dorn, G.W., Liggett, S.B. Circ. Res. (2000) [Pubmed]
  13. Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus. Carvalho, M.R., Sato, E.I., Tebexreni, A.S., Heidecher, R.T., Schenkman, S., Neto, T.L. Arthritis Rheum. (2005) [Pubmed]
  14. The hemodynamic and metabolic effects of shivering during acute normovolemic hemodilution. Perez-de-Sá, V., Cunha-Goncalves, D., Schou, H., Jonmarker, C., Werner, O. Anesth. Analg. (2003) [Pubmed]
  15. Central dopamine modulates anapyrexia but not hyperventilation induced by hypoxia. Barros, R.C., Branco, L.G. J. Appl. Physiol. (2002) [Pubmed]
  16. The effects of beta1-adrenergic blockade on cardiovascular oxygen flow in normoxic and hypoxic humans at exercise. Ferretti, G., Licker, M.J., Anchisi, S., Moia, C., Susta, D., Morel, D.R. Eur. J. Appl. Physiol. (2005) [Pubmed]
  17. Energy expenditure by Ba(2+) contracture in rat ventricular slices derives from cross-bridge cycling. Kohzuki, H., Misawa, H., Sakata, S., Ohga, Y., Suga, H., Takaki, M. Am. J. Physiol. (1999) [Pubmed]
  18. Evidence for aerobic insufficiency in women with systemic Lupus erythematosus. Keyser, R.E., Rus, V., Cade, W.T., Kalappa, N., Flores, R.H., Handwerger, B.S. Arthritis Rheum. (2003) [Pubmed]
  19. The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients. Taivassalo, T., Jensen, T.D., Kennaway, N., DiMauro, S., Vissing, J., Haller, R.G. Brain (2003) [Pubmed]
  20. Atriobiventricular pacing improves exercise capacity in patients with heart failure and intraventricular conduction delay. Varma, C., Sharma, S., Firoozi, S., McKenna, W.J., Daubert, J.C. J. Am. Coll. Cardiol. (2003) [Pubmed]
  21. The effects of exercise training on sympathetic neural activation in advanced heart failure: a randomized controlled trial. Roveda, F., Middlekauff, H.R., Rondon, M.U., Reis, S.F., Souza, M., Nastari, L., Barretto, A.C., Krieger, E.M., Negrão, C.E. J. Am. Coll. Cardiol. (2003) [Pubmed]
  22. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. O'Donnell, D.E., Revill, S.M., Webb, K.A. Am. J. Respir. Crit. Care Med. (2001) [Pubmed]
  23. Effect of exercise intensity on skeletal muscle AMPK signaling in humans. Chen, Z.P., Stephens, T.J., Murthy, S., Canny, B.J., Hargreaves, M., Witters, L.A., Kemp, B.E., McConell, G.K. Diabetes (2003) [Pubmed]
  24. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent. Narla, R.K., Dong, Y., D'Cruz, O.J., Navara, C., Uckun, F.M. Clin. Cancer Res. (2000) [Pubmed]
  25. Effect of gender on lipid kinetics during endurance exercise of moderate intensity in untrained subjects. Mittendorfer, B., Horowitz, J.F., Klein, S. Am. J. Physiol. Endocrinol. Metab. (2002) [Pubmed]
  26. Functional and desensitizing effects of the novel synthetic vanilloid-like agent 12-phenylacetate 13-acetate 20-homovanillate (PPAHV) in the perfused rat hindlimb. Griffiths, C.D., Vincent, M.A., Szallasi, A., Colquhoun, E.Q., Geraghty, D.P. Br. J. Pharmacol. (2000) [Pubmed]
  27. Invited Review: pulmonary alveoli: formation, the "call for oxygen," and other regulators. Massaro, D., Massaro, G.D. Am. J. Physiol. Lung Cell Mol. Physiol. (2002) [Pubmed]
  28. Exercise-induced improvement in vasodilatory function accompanies increased insulin sensitivity in obesity and type 2 diabetes mellitus. De Filippis, E., Cusi, K., Ocampo, G., Berria, R., Buck, S., Consoli, A., Mandarino, L.J. J. Clin. Endocrinol. Metab. (2006) [Pubmed]
  29. Metal dependency for transcription factor rho activation. Weber, T.P., Widger, W.R., Kohn, H. Biochemistry (2003) [Pubmed]
  30. Increasing P(50) does not improve DO(2CRIT) or systemic VO(2) in severe anemia. Eichelbrönner, O., D'Almeida, M., Sielenkämper, A., Sibbald, W.J., Chin-Yee, I.H. Am. J. Physiol. Heart Circ. Physiol. (2002) [Pubmed]
  31. TRH microdialysis into the RTN of the conscious rat increases breathing, metabolism, and temperature. Cream, C., Nattie, E., Li, A. J. Appl. Physiol. (1999) [Pubmed]
  32. Fitness, training, and the growth hormone-->insulin-like growth factor I axis in prepubertal girls. Eliakim, A., Scheett, T.P., Newcomb, R., Mohan, S., Cooper, D.M. J. Clin. Endocrinol. Metab. (2001) [Pubmed]
  33. Effects of one bout of endurance exercise on the expression of myogenin in human quadriceps muscle. Kadi, F., Johansson, F., Johansson, R., Sjöström, M., Henriksson, J. Histochem. Cell Biol. (2004) [Pubmed]
  34. Serum bFGF levels are reduced in Japanese overweight men and restored by a 6-month exercise education. Seida, A., Wada, J., Kunitomi, M., Tsuchiyama, Y., Miyatake, N., Fujii, M., Kira, S., Takahashi, K., Shikata, K., Makino, H. Int. J. Obes. Relat. Metab. Disord. (2003) [Pubmed]
  35. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Maltais, F., LeBlanc, P., Whittom, F., Simard, C., Marquis, K., Bélanger, M., Breton, M.J., Jobin, J. Thorax (2000) [Pubmed]
  36. Selection of patients for heart transplantation in the current era of heart failure therapy. Butler, J., Khadim, G., Paul, K.M., Davis, S.F., Kronenberg, M.W., Chomsky, D.B., Pierson, R.N., Wilson, J.R. J. Am. Coll. Cardiol. (2004) [Pubmed]
  37. Selective low-level leg muscle training alleviates dyspnea in patients with heart failure. Beniaminovitz, A., Lang, C.C., LaManca, J., Mancini, D.M. J. Am. Coll. Cardiol. (2002) [Pubmed]
 
WikiGenes - Universities